Minyang Fu
- Immunology top 5%
- Immunotherapy and Immune Responses 1
- Oncology top 5%
- Cancer Cells and Metastasis 2
- Cancer Research top 10%
- Cell Biology top 5%
- Hippo pathway signaling and YAP/TAZ 1
- Molecular Biology top 10%
- vaccines and immunoinformatics approaches 1
- RNA modifications and cancer 1
- Fibroblast Growth Factor Research 1
-
- SARS-CoV-2 and COVID-19 Research 1
-
- Liver physiology and pathology 1
- Cited by
- ImmunologyOncologyCancer Research
- Journals
- Molecular Cancer (2 papers)Signal Transduction and Targeted Therapy (2 papers)Acta Pharmaceutica Sinica B (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Minyang Fu
7 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 99
- Immunology 496
- Oncology 510
- Cancer Research 224
- Cell Biology 232
- Molecular Biology 809
Countries citing papers authored by Minyang Fu
This map shows the geographic impact of Minyang Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minyang Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minyang Fu more than expected).
Fields of papers citing papers by Minyang Fu
This network shows the impact of papers produced by Minyang Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minyang Fu. The network helps show where Minyang Fu may publish in the future.
Co-authorship network
The 24 scholars most cited alongside Minyang Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 76 | |
| 4 | 2022 | 57 | |
| 5 | The Hippo signalling pathway and its implications in human health and diseasesbreakdown → | 2022 | 358 |
| 6 | Targeting TGF-β signal transduction for fibrosis and cancer therapybreakdown → | 2022 | 655 |
| 7 | Cancer vaccines as promising immuno-therapeutics: platforms and current progressbreakdown → | 2022 | 473 |
About Minyang Fu
Minyang Fu is a scholar working on Hepatology, Health, Animal Science and Zoology, Oncology and Molecular Biology, having authored 7 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (2 papers), vaccines and immunoinformatics approaches (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper), RNA modifications and cancer (1 paper), Fibroblast Growth Factor Research (1 paper), Hippo pathway signaling and YAP/TAZ (1 paper), Immunotherapy and Immune Responses (1 paper) and Liver physiology and pathology (1 paper). The work is most often cited by research in Immunology (496 citations), Oncology (510 citations), Cancer Research (224 citations), Cell Biology (232 citations) and Molecular Biology (809 citations). Minyang Fu has collaborated with scholars based in China and United States. Frequent co-authors include Yuquan Wei, Manni Wang, Dandan Peng, Xiawei Wei, Xiawei Wei, Jian Liu, Dandan Wan, Min Luo, Yuan Hu and Tianxia Lan. Their work appears in journals such as Molecular Cancer, Signal Transduction and Targeted Therapy, Acta Pharmaceutica Sinica B, Journal of Hematology & Oncology and Genes & Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.